ArticleFrontiers in pharmacology2020

DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Andrija Smelcerovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.